225 related articles for article (PubMed ID: 28126436)
21. Novel spirooxindole-pyrrolidine compounds: synthesis, anticancer and molecular docking studies.
Arun Y; Saranraj K; Balachandran C; Perumal PT
Eur J Med Chem; 2014 Mar; 74():50-64. PubMed ID: 24445312
[TBL] [Abstract][Full Text] [Related]
22. Facile and diastereoselective synthesis of 3,2'-spiropyrrolidine-oxindoles derivatives, their molecular docking and antiproliferative activities.
Kathirvelan D; Haribabu J; Reddy BS; Balachandran C; Duraipandiyan V
Bioorg Med Chem Lett; 2015 Jan; 25(2):389-99. PubMed ID: 25435149
[TBL] [Abstract][Full Text] [Related]
23. Spiro[pyrrolidine-3, 3´-oxindole] as potent anti-breast cancer compounds: Their design, synthesis, biological evaluation and cellular target identification.
Hati S; Tripathy S; Dutta PK; Agarwal R; Srinivasan R; Singh A; Singh S; Sen S
Sci Rep; 2016 Aug; 6():32213. PubMed ID: 27573798
[TBL] [Abstract][Full Text] [Related]
24. Fe
Maddela S; Makula A; Galigniana MD; Parambi DGT; Federicci F; Mazaira G; Hendawy OM; Dev S; Mathew GE; Mathew B
Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800174. PubMed ID: 30485473
[TBL] [Abstract][Full Text] [Related]
25. The discovery of oxazolones-grafted spirooxindoles via three-component diversity oriented synthesis and their preliminary biological evaluation.
Dong H; Song S; Li J; Xu C; Zhang H; Ouyang L
Bioorg Med Chem Lett; 2015 Sep; 25(17):3585-91. PubMed ID: 26159483
[TBL] [Abstract][Full Text] [Related]
26. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
[TBL] [Abstract][Full Text] [Related]
27. Targeting triple-negative breast cancer cells with 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles.
Santos K; Laranjo M; Abrantes AM; Brito AF; Gonçalves C; Sarmento Ribeiro AB; Botelho MF; Soares MI; Oliveira AS; Pinho e Melo TM
Eur J Med Chem; 2014 May; 79():273-81. PubMed ID: 24747064
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, structure, antimycobacterial and anticancer evaluation of new pyrrolo-phenanthroline derivatives.
Al Matarneh CM; Mangalagiu II; Shova S; Danac R
J Enzyme Inhib Med Chem; 2016; 31(3):470-80. PubMed ID: 25945747
[TBL] [Abstract][Full Text] [Related]
29. Chiral 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles with anti-breast cancer properties.
Soares MI; Brito AF; Laranjo M; Paixão JA; Botelho MF; Pinho e Melo TM
Eur J Med Chem; 2013 Feb; 60():254-62. PubMed ID: 23313634
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and anticancer properties of novel oxa/azaspiro[4,5]trienones as potent apoptosis inducers through mitochondrial disruption.
Yugandhar D; Nayak VL; Archana S; Shekar KC; Srivastava AK
Eur J Med Chem; 2015 Aug; 101():348-57. PubMed ID: 26163220
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological activity of 4-aryl-3-benzoyl-5-phenylspiro[pyrrolidine-2.3'-indolin]-2'-one derivatives as novel potent inhibitors of advanced glycation end product.
Kaur A; Singh B; Vyas B; Silakari O
Eur J Med Chem; 2014 May; 79():282-9. PubMed ID: 24747065
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of Spiro[indole-3,5'-isoxazoles] with Anticancer Activity via a Formal [4 + 1]-Spirocyclization of Nitroalkenes to Indoles.
Aksenov AV; Aksenov DA; Arutiunov NA; Aksenov NA; Aleksandrova EV; Zhao Z; Du L; Kornienko A; Rubin M
J Org Chem; 2019 Jun; 84(11):7123-7137. PubMed ID: 31070030
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and antibreast cancer MCF-7 cells biological evaluation of heterocyclic analogs of resveratrol.
Du C; Dong MH; Ren YJ; Jin L; Xu C
J Asian Nat Prod Res; 2017 Sep; 19(9):890-902. PubMed ID: 27809606
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and in vitro antiproliferative activity of novel Dasatinib derivatives.
Cai J; Zhang S; Zheng M; Wu X; Chen J; Ji M
Bioorg Med Chem Lett; 2012 Jan; 22(2):806-10. PubMed ID: 22217877
[TBL] [Abstract][Full Text] [Related]
35. Facile one-pot synthesis of novel dispirooxindole-pyrrolidine derivatives and their antimicrobial and anticancer activity against A549 human lung adenocarcinoma cancer cell line.
Arun Y; Bhaskar G; Balachandran C; Ignacimuthu S; Perumal PT
Bioorg Med Chem Lett; 2013 Mar; 23(6):1839-45. PubMed ID: 23395665
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and biological evaluation of nitroisoxazole-containing spiro[pyrrolidin-oxindole] derivatives as novel glutathione peroxidase 4/mouse double minute 2 dual inhibitors that inhibit breast adenocarcinoma cell proliferation.
Liu SJ; Zhao Q; Peng C; Mao Q; Wu F; Zhang FH; Feng QS; He G; Han B
Eur J Med Chem; 2021 May; 217():113359. PubMed ID: 33725632
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of pyrrolo(spiro-[2.3']-oxindole)-spiro-[4.3"]-oxindole via 1,3-dipolar cycloaddition of azomethine ylides with 3-acetonylideneoxindole.
Xiao JA; Zhang HG; Liang S; Ren JW; Yang H; Chen XQ
J Org Chem; 2013 Nov; 78(22):11577-83. PubMed ID: 24111532
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of first ever 4-quinolone-3-carboxylic acid-appended spirooxindole-pyrrolidine derivatives and their biological applications.
Arasakumar T; Mathusalini S; Ata A; Shankar R; Gopalan S; Lakshmi K; Sakthivel P; Mohan PS
Mol Divers; 2017 Feb; 21(1):37-52. PubMed ID: 27670880
[TBL] [Abstract][Full Text] [Related]
39. Efficient and regioselective synthesis of novel functionalized dispiropyrrolidines and their cytotoxic activities.
Yang JM; Hu Y; Li Q; Yu F; Cao J; Fang D; Huang ZB; Shi DQ
ACS Comb Sci; 2014 Mar; 16(3):139-45. PubMed ID: 24517857
[TBL] [Abstract][Full Text] [Related]
40. Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies.
Eldehna WM; Abo-Ashour MF; Nocentini A; Gratteri P; Eissa IH; Fares M; Ismael OE; Ghabbour HA; Elaasser MM; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2017 Oct; 139():250-262. PubMed ID: 28802125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
